Mutation of the proline P81 into a serine modifies the tumour suppressor function of the von Hippel–Lindau gene in the ccRCC

Franck Chesnel,Emmanuelle Jullion,Olivier Delalande,Anne Couturier,Adrien Alusse,Xavier Le Goff,Marion Lenglet,Betty Gardie,Caroline Abadie,Yannick Arlot-Bonnemains
DOI: https://doi.org/10.1038/s41416-022-01985-2
IF: 9.075
2022-09-30
British Journal of Cancer
Abstract:The von Hippel–Lindau disease is an autosomal dominant syndrome associated with tumour formation in various tissues, such as retina, central nervous system, kidney, and adrenal glands. VHL gene deletion or mutations support the development of various cancers. Unclassified VHL variants also referred as "of unknown significance" result from gene mutations that have an unknown or unclear effect on protein functions. The P81S mutation has been linked to low penetrance Type 1 disease but its pathogenic function was not clearly determined.
oncology
What problem does this paper attempt to address?